PT931264E - Metodo de diagnostico da aterosclerose - Google Patents

Metodo de diagnostico da aterosclerose

Info

Publication number
PT931264E
PT931264E PT97939603T PT97939603T PT931264E PT 931264 E PT931264 E PT 931264E PT 97939603 T PT97939603 T PT 97939603T PT 97939603 T PT97939603 T PT 97939603T PT 931264 E PT931264 E PT 931264E
Authority
PT
Portugal
Prior art keywords
diagnostic method
aterosclerosis
level
chlorotyrosine
atherosclerosis
Prior art date
Application number
PT97939603T
Other languages
English (en)
Inventor
Jay W Heinecke
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of PT931264E publication Critical patent/PT931264E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Hydrogenated Pyridines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
PT97939603T 1996-09-09 1997-09-03 Metodo de diagnostico da aterosclerose PT931264E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/709,916 US6268220B1 (en) 1996-09-09 1996-09-09 Diagnostic method for atherosclerosis

Publications (1)

Publication Number Publication Date
PT931264E true PT931264E (pt) 2002-08-30

Family

ID=24851820

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97939603T PT931264E (pt) 1996-09-09 1997-09-03 Metodo de diagnostico da aterosclerose

Country Status (11)

Country Link
US (1) US6268220B1 (pt)
EP (1) EP0931264B1 (pt)
JP (1) JP3553611B2 (pt)
AT (1) ATE216495T1 (pt)
AU (1) AU4165197A (pt)
CA (1) CA2264757C (pt)
DE (1) DE69712079T2 (pt)
DK (1) DK0931264T3 (pt)
ES (1) ES2175453T3 (pt)
PT (1) PT931264E (pt)
WO (1) WO1998010294A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306576B1 (en) 1999-02-19 2001-10-23 Cleveland Clinic Foundation Diagnostic methods for asthma
US6548252B1 (en) * 2000-10-13 2003-04-15 Esa, Inc. Detection of DNA damage
US7223552B2 (en) 2001-01-02 2007-05-29 The Cleveland Clinic Foundation Myeloperoxidase, a risk indicator for cardiovascular disease
US7780950B2 (en) * 2002-01-02 2010-08-24 The Cleveland Clinic Foundation Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
US20040132123A1 (en) * 2001-05-09 2004-07-08 Oron Yacoby-Zeevi Methods and kits utilizing heparanase as a diagnostic marker for haemostatic disorders
US6939716B2 (en) * 2001-09-19 2005-09-06 Washington University Method for detecting conditions indicative of sepsis
AU2003247667A1 (en) 2002-07-01 2004-01-19 University Of Rochester Medical Center Method for determination of likelihood of occurrence of preterm labor in pregnant females
US7459286B1 (en) 2003-10-22 2008-12-02 The Cleveland Clinic Foundation Assessing the risk of a major adverse cardiac event in patients with chest pain
AU2004296829A1 (en) 2003-12-05 2005-06-23 The Cleveland Clinic Foundation Risk markers for cardiovascular disease
US7749729B2 (en) * 2004-07-19 2010-07-06 University Of Washington Methods for assessing the risk for development of cardiovascular disease
WO2006020498A2 (en) 2004-08-11 2006-02-23 The Cleveland Clinic Foundation Therapeutic agents and methods for cardiovascular disease
DE102004042530B4 (de) * 2004-09-02 2006-10-19 Mosaiques Diagnostics And Therapeutics Ag Verfahren zur Diagnose von Arteriosklerose
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease
JP2013541560A (ja) * 2010-10-19 2013-11-14 バテル・メモリアル・インスティテュート 組成物、抗体、喘息診断方法、及び抗体の調製方法
US9606082B2 (en) 2015-05-11 2017-03-28 The University Of North Carolina At Chapel Hill Pressure driven microfluidic injection for chemical separations
US10734216B2 (en) 2015-05-11 2020-08-04 The University Of North Carolina At Chapel Hill Pressure driven fluidic injection for chemical separations by electrophoresis
US9728387B2 (en) 2015-10-20 2017-08-08 The University Of North Carolina At Chapel Hill Solid phase extraction with capillary electrophoresis

Also Published As

Publication number Publication date
JP2001500257A (ja) 2001-01-09
EP0931264A1 (en) 1999-07-28
CA2264757C (en) 2005-10-04
JP3553611B2 (ja) 2004-08-11
ATE216495T1 (de) 2002-05-15
US6268220B1 (en) 2001-07-31
DK0931264T3 (da) 2002-08-05
WO1998010294A1 (en) 1998-03-12
AU4165197A (en) 1998-03-26
DE69712079T2 (de) 2002-10-02
ES2175453T3 (es) 2002-11-16
DE69712079D1 (de) 2002-05-23
CA2264757A1 (en) 1998-03-12
EP0931264B1 (en) 2002-04-17

Similar Documents

Publication Publication Date Title
PT931264E (pt) Metodo de diagnostico da aterosclerose
PT931265E (pt) Metodo de diagnostico da aterosclerose
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
NO971348D0 (no) Pröveenhet for oppsamling og undersökelse av kroppsvæske
DE69635174D1 (de) Nichtinvasive Vorrichtung zur Blutuntersuchung
AU1726797A (en) A method for monitoring the health of a patient by measuring and predicting the glucose level of the patient's blood sample
DE69623628D1 (de) Virtuelles medizinisches instrument zum medizinischen diagnostiktesten von patienten
BR9611423A (pt) Peça manual de instrumento cirúrgico e sistema
FR2753897B1 (fr) Dispositif pour le diagnostic endoscopique photodynamique de tissu tumoral
DE69732223D1 (de) Ultraschall-Echographiesystem zur Untersuchung von Arterien
DE69601544T2 (de) Harnsammel und Untersuchungsvorrichtung, und Gebrauchsverfahren
EP0924523A3 (de) Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen
HU9202178D0 (en) Method for detecting irregularities of bone and other connective tissues in human beings and in animals
SE9401883L (sv) Sätt vid diagnosticering av födoämnesintolerans/allergi samt instrument för diagnostiseringen
NO971251D0 (no) Pröveenhet for engangsbruk, for undersökelse av kroppsvæske
ZA98665B (en) Method and apparatus for the measurement of blood coagulation properties with absorbent materials
AU4756396A (en) Medical probe device with scope and proximal aspiraton openings and method for treatment of the prostate with same
DE68911574T2 (de) Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür.
WO1992005278A3 (en) Method for the determination of the differential expression of mrna for the amyloid precursor protein (app)
ATE220458T1 (de) Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten
FR2714812B1 (fr) Procédé de stérilisation d'instruments chirurgicaux et autoclave permettant de la mettre en Óoeuvre.
DE69522935D1 (de) Verfahren zur Erfassung der Geschwindigkeit von Gewebe oder Blut und Ultraschall-Diagnosevorrichtung
WO1994016103A3 (en) Detection of synthetic oligonucleotides extracted from body fluids or tissues
FR2724111B1 (fr) Dispositif hydraulique de traitement medical des troubles vasculaires et des oedemes des membres inferieurs et superieurs du corps humain
IT1276615B1 (it) Metodo per la rivelazione di catecolamine durante il ritmo circadiano, uso di detto metodo per la diagnosi e la terapia di malattie nervose